AusperBio: Funding, Investors & Team (Sep 2026)
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
AusperBio has raised $183M across 2 funding rounds on record, the most recent a Series C of $120M announced in Aug 2026.
That round is above the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AusperBio Company Profile and Key Stats
Latest funding round on record: Aug 2026.
AusperBio Funding Rounds
AusperBio raised $63.0M in a Series B announced in Sep 2025.
11 months later, a Series C of $120M was announced in Aug 2026.
AusperBio Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
AusperBio Founders and Leadership Team
Contact details for the AusperBio team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →AusperBio Funding Compared to Other Biotechnology Startups
AusperBio's latest round of $120M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AusperBio in Biotechnology and Foster City
Companies Similar to AusperBio
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Enlaza Therapeutics is a biotechnology research company.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
AusperBio Funding FAQs
What does AusperBio do?
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
How much funding has AusperBio raised?
AusperBio has raised $183M across 2 rounds on record. The most recent is a Series C of $120M announced in Aug 2026.
When did AusperBio last raise funding?
AusperBio's most recent funding round on record is a Series C of $120M, announced in Aug 2026.
Who has invested in AusperBio?
Investors on record for AusperBio include RA Capital Management, Qiming Venture Partners, CDH Investments, Genesis Capital, BioVenture. FundedIQ records 11 investors in total.
Who is the CEO of AusperBio?
Guofeng Cheng is listed as CEO at AusperBio.
Where is AusperBio headquartered?
AusperBio is based in Foster City, United States.
How many employees does AusperBio have?
AusperBio is in the 101-250 employee band.
When was AusperBio founded?
AusperBio was founded in 2019.
How does AusperBio's funding compare to other Biotechnology startups?
AusperBio's latest round of $120M is above the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's AusperBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AusperBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.